Congress Materials – Neuroscience Education Institute Congress
2024 Neuroscience Education Institute Congress | Nov 7-10 | Colorado Springs, CO
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Efficacy and Safety of Esketamine Nasal Spray as Monotherapy in Adults with Treatment-Resistant Depression: A Randomized, Double-Blind, Placebo-Controlled Study
Adam Janik, Xin Qiu, Rosanne Lane, Vanina Popova, Wayne C. Drevets, Carla M. Canuso, Dong Jing Fu
How do Patients with Depression and their Providers Talk about Anhedonia? An Ethnographic Analysis of Healthcare Provider Conversations with Patients in the Clinical Setting
Tiina Drissen, Chelsea McCracken, Hrishikesh Kale, Zachary Hebert, Craig Chepke
Impact of Major Depressive Disorder with Prominent Anhedonia on Polypharmacy, Resource Utilization, and Humanistic Outcomes in the United States
Hrishikesh Kale, Michael L. Ganz, Rajrupa Ghosh, Cynthia Saiontz-Martinez, Tiina Drissen, Andrew J. Cutler
Long-Term Efficacy of Esketamine Nasal Spray Dosed in Accordance With US Prescribing Information in Adults With Treatment-Resistant Depression: A Subgroup Analysis of the SUSTAIN-3 Study
John Zajecka, Naim Zaki, Dong-Jing Fu, Ibrahim Turkoz, Patricia Cabrera, Oliver Lopena, Phung Quach, Meredith Castro
Long-Term Safety and Efficacy of Esketamine Nasal Spray by Dosing Frequency in Adults With Treatment-Resistant Depression: Analysis of the SUSTAIN-3 Study
John Zajecka, Dong-Jing Fu, Naim Zaki, Ibrahim Turkoz, Patricia Cabrera, Oliver Lopena, Manish Patel, Sherry Fua
Long-Term Safety of Esketamine Nasal Spray Dosed in Accordance With US Prescribing Information in Adults With Treatment-Resistant Depression: a Subgroup Analysis of the SUSTAIN-3 Study
John Zajecka, Naim Zaki, Dong-Jing Fu, Ibrahim Turkoz, Patricia Cabrera, Oliver Lopena, Manish Patel, Susan Lakey Kevo
National Real-World Study of the Patient Journey of Dually Eligible Medicare Enrollees With Schizophrenia: A Call to Action for Improving Care Quality
Pengxiang Li, Zhi Geng, Carmela Benson, Charmi Patel, Jalpa A. Doshi
Unraveling the Treatment Preferences of Patients and Healthcare Providers in Treatment-Resistant Depression: A Targeted Literature Review
Joshua M. Hamilton, Yuxian Du, Hui Lu, Kruti Joshi, Jennifer A. Whitty, Rosanne Janssens, Chinwe Adebiyi
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.